PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Cell Physiol. Author manuscript; available in PMC Mar 29, 2011.
Published in final edited form as:
PMCID: PMC3065715
NIHMSID: NIHMS173978
Tissue Stretch Decreases Soluble TGF-β1 and Type-1 Procollagen in Mouse Subcutaneous Connective Tissue: Evidence From Ex Vivo and In Vivo Models
Nicole A. Bouffard,1 Kenneth R. Cutroneo,2 Gary J. Badger,3 Sheryl L. White,4 Thomas R. Buttolph,4 H. Paul Ehrlich,5 Debbie Stevens-Tuttle,1 and Helene M. Langevin1*
1Department of Neurology, University of Vermont College of Medicine, Burlington, Vermont
2Department of Biochemistry, University of Vermont College of Medicine, Burlington, Vermont
3Department of Medical Biostatistics, University of Vermont College of Medicine, Burlington, Vermont
4Department of Anatomy & Neurobiology, University of Vermont College of Medicine, Burlington, Vermont
5Department of Surgery, Hershey Medical Center, Hershey, Pennsylvania
* Correspondence to: Helene M. Langevin, Department of Neurology, University of Vermont, 89 Beaumont Ave., Burlington, VT 05405. helene.langevin/at/uvm.edu
Transforming growth factor beta 1 (TGF-β1) plays a key role in connective tissue remodeling, scarring, and fibrosis. The effects of mechanical forces on TGF-β1 and collagen deposition are not well understood. We tested the hypothesis that brief (10 min) static tissue stretch attenuates TGF-β1-mediated new collagen deposition in response to injury. We used two different models: (1) an ex vivo model in which excised mouse subcutaneous tissue (N = 44 animals) was kept in organ culture for 4 days and either stretched (20% strain for 10 min 1 day after excision) or not stretched; culture media was assayed by ELISA for TGF-β1; (2) an in vivo model in which mice (N = 22 animals) underwent unilateral subcutaneous microsurgical injury on the back, then were randomized to stretch (20–30% strain for 10 min twice a day for 7 days) or no stretch; subcutaneous tissues of the back were immunohistochemically stained for Type-1 procollagen. In the ex vivo model, TGF-β1 protein was lower in stretched versus non-stretched tissue (repeated measures ANOVA, P < 0.01). In the in vivo model, microinjury resulted in a significant increase in Type-1 procollagen in the absence of stretch (P < 0.001), but not in the presence of stretch (P = 0.21). Thus, brief tissue stretch attenuated the increase in both soluble TGF-β1 (ex vivo) and Type-1 procollagen (in vivo) following tissue injury. These results have potential relevance to the mechanisms of treatments applying brief mechanical stretch to tissues (e.g., physical therapy, respiratory therapy, mechanical ventilation, massage, yoga, acupuncture).
Transforming growth factor β1 (TGF-β1) is well-established as one of the key cytokines regulating the response of fibroblasts to injury, as well as the pathological production of fibrosis (Barnard et al., 1990; Sporn and Roberts, 1990; Leask and Abraham, 2004). Tissue injury is known to cause auto-induction of TGF-β1 protein production and secretion (Van Obberghen-Schilling et al., 1988; Morgan et al., 2000). Elevated extracellular levels of TGF-β1 have a major impact on extracellular matrix composition by causing autocrine and paracrine activation of fibroblast cell surface receptors, leading to increased synthesis of collagens, elastin, proteoglycans, fibronectin, and tenascin (Balza et al., 1988; Bassols and Massague, 1988; Kahari et al., 1992; Cutroneo, 2003). In vivo, connective tissue remodeling is not limited to tissue injury, but also occurs in response to changing levels of tissue mechanical forces (e.g., immobilization, beginning a new exercise or occupation). Long-standing physical therapy practices also suggest that externally applied mechanical forces can be used to reduce collagen deposition during tissue repair and scar formation (Cummings and Tillman, 1992). The mechanisms underlying these effects, however, are not well understood. In this study, we have used an ex vivo mouse subcutaneous tissue explant model and an in vivo mouse microinjury model to examine the effect of applying brief (10 min), static mechanical stretch on TGF-β1 and Type-1 procollagen in response to subcutaneous tissue injury.
The experimental protocols used in these experiments were approved the University of Vermont IACUC Committee. All mice were male C57Black6 weighing 19–21 g.
Ex vivo mouse tissue explant study design
We first examined the time course of TGF-β1 protein (per mg tissue) and lactate dehydrogenase (LDH) (per mg tissue) concentration in the culture media at days 0, 1, and 3 post-stretch (or no stretch), with stretch occurring 1-day post-excision. The time course experiment was based on 8 mice (one sample per mouse) cultured and assayed in stretch/no-stretch pairs. Additional samples (N = 36 mice, paired for stretch/no stretch factor) were then assayed on day 3 post-stretch (or no stretch).
Ex vivo equipment and tissue preparation
All equipment was rinsed in 70% ethanol/dH2O for 15 min (min) then air-dried. Immediately after death by decapitation, a 2 cm × 5cm flap of tissue containing dermis, subcutaneous muscle, and subcutaneous tissue was excised from the trunk of each mouse and viewed under a dissecting microscope. The subcutaneous tissue layer was dissected as a continuous sheet while applying minimal traction to the tissue. Samples were incubated for 24 h floating in separate culture wells at 37°C each containing 670 μl of 37°C Dulbecco's Modified Eagle Medium (DMEM F-12 Ham) 1:1 (containing 15 mM HEPES buffer) with penicillin/streptomycin (1–100 ml DMEM) (Invitrogen Corporation, Carlsbad, CA) and without added serum.
Ex vivo tissue stretch
After 24 h of incubation, tissue samples were placed in grips and immersed in an incubation bath containing DMEM at 37°C with the proximal grip connected to a 4.9 Newtons (500 g) capacity load cell as previously described (Langevin et al., 2005). Tissue samples were elongated at a rate of 1 mm/sec by advancing a micrometer connected to the distal tissue grip until 19.6 milliNewtons (2 g) of preload was achieved. The tissue was then further stretched to 20% beyond preload length and incubated at that final length for 10 min. Control samples were placed in grips and incubated for 10 min without stretch. The samples were then removed from the grips, returned to the culture wells and incubated for an additional 3 days with a culture medium change on day 2 post-stretch (or no stretch). No tension was applied to the tissue during the post-stretch incubation period.
Ex vivo TGF-β1 and LDH assays
Aliquots of 600 μl DMEM were harvested from the tissue culture wells on specified days and immediately assayed for (1) TGF-β1 protein using a human TGF-β1 ELISA assay (R&D Systems, Minneapolis, MN) including sample acidification with 1N hydrochloric acid for activation of latent TGF-β1 and (2) LDH, an indicator of cell death due to necrosis or apoptosis (Loo and Rillema, 1998), measured by reflectance spectrophotometry on an Ortho Clinical Diagnostics Instrument (Johnson & Johnson, New Brunswick, NJ).
Ex vivo tissue viability stain
One pair of stretched and non-stretched tissue samples was incubated for 3 days post-stretch and stained as whole tissue mounts (30–50 μm thickness) with a Live (green)/Dead (red) assay kit (Molecular Probes, Eugene, OR) at 1:500 and imaged with a Bio-Rad MRC 1024 confocal microscope (Bio-Rad Microsciences, Hercules, CA) using a 20 × objective and 568 nanometer laser excitation and iris aperture of 2.7 and software package LaserSharp 2000.
In vivo microinjury study design
Twenty-two mice first underwent unilateral microsurgical subcutaneous tissue injury on the back, and were then randomized to either stretch or no stretch (10 min twice a day for 7 days). The mice were sacrificed at day 7, subcutaneous tissues of the back were harvested and stained for Type-1 procollagen using indirect immunohistochemistry.
Microsurgery procedure
Under isoflurane anesthesia, a 5 mm incision was performed in the middle of the back of mice at the level of the scapula. A microsurgery blade was then used to cut the subcutaneous tissue attachments between the subcutaneous (pannicular) muscle and the back muscles over a 1.5 cm × 1.5 cm area on one side of the back lateral to the midline with the other side serving as the control (Fig. 1A). One mouse in the stretch group was eliminated due to a bacterial wound infection, thus the final sample size was 21 (10 and 11 for stretch and no stretch conditions, respectively).
Fig. 1
Fig. 1
A: In vivo mouse microinjury procedure. A microsurgery blade is introduced subcutaneously via a 5 mm midline incision. The subcutaneous tissue layer is cut over a 1.5 cm × 1.5 cm area on one side of the back lateral to the midline with the other (more ...)
In vivo tissue stretch method
In the stretch group, the mice underwent stretching of the trunk for 10 min twice a day for 7 days in the following manner: each mouse was suspended by the tail such that its paws barely touched a surface slightly inclined relative to the vertical. In response to this maneuver, the mouse spontaneously extended its front and hind limbs (Fig. 1B) with the distance between ipsilateral hip and shoulder joints becoming 20–30% greater than the resting distance. Mice in the no-stretch group were observed for 7 days without stretch. Seven days after injury, all mice were sacrificed by decapitation. The skin of the back, including subcutaneous tissues, was excised and fixed for 2 h in 3% paraformaldehyde in phosphate buffered saline (PBS).
Type I procollagen immunohistochemistry
Following fixation, subcutaneous tissue samples (1 cm ×1 cm and 30–50 μm thickness) were dissected from the same location (centered 1 cm lateral to the spine at the level of the surgical incision) and mounted on glass slides. Immunohistochemistry was performed on the whole tissue mounts for the detection of Type-I Procollagen using indirect immunofluorescence with a primary rabbit monospecific polyclonal antibody (Shull and Cutroneo, 1983) at a dilution of 1:100 in PBS/1.0% BSA/0.1% triton and a CY3 secondary goat anti-rabbit antibody (Invitrogen Corporation) at a dilution of 1:500 in PBS/1.0% BSA/0.1%triton. Following secondary antibody staining, samples were rinsed in PBS/1.0% BSA for 10 min and then overlaid with a glass coverslip using 50% glycerol in PBS with 1% N-propylgallate as a mounting medium.
Quantitative evaluation of subcutaneous tissue Type I procollagen
Type-1 procollagen immunoreactivity was measured by quantifying Cy3 fluorescence intensity using the same detection threshold across all samples. For each immunostained sample, three fields chosen by a blinded investigator and imaged using a Zeiss LSM 510 META scanning laser confocal microscope at 63×. Fluorescence intensity was measured in projected three-dimensional stacks of images (nine serial optical sections at 0.76 μm inter-image interval) using Metamorph image analysis software (version 6.0; Universal Imaging Corporation, Downington, PA). Results are expressed as percent staining area (staining area over total imaged area).
Statistical methods
Repeated measures analyses of variance were performed to test for differences in mean TGF-β1 and LDH concentrations between stretch and no stretch conditions and to examine temporal changes in these measurements. Because each animal assigned to stretch was paired (during incubation and ELISA assay) with a corresponding animal assigned to non-stretch, animal-pair was an additional factor in the analysis of variance (ANOVA). ANOVA also was used to analyze the effects of stretch on TGF-β1 concentrations at day 3 post-stretch, with stretch as a within-pair factor. For these analyses, TGF-β1 and LDH data were log transformed prior to analysis in order to satisfy the normality and homogeneity of variance assumptions associated with the ANOVA, which were examined based on residual plots. Means presented in the text and figures for these outcome measures are geometric means to be consistent with the log transformed analyses. For the in vivo experiment, repeated measures analysis of variance was also used to analyze the effects of stretch and injury on Type-I procollagen. For these analyses, stretch was an across-animal factor and injury was a within-animal (across-side) factor. Statistical analyses were performed using SAS statistical software (PROC MIXED).
Effect of stretch on TGF-β1 ex vivo
In ex vivo short-term organ cultures of mouse subcutaneous tissue explants, TGF-β1 protein levels in the culture media increased significantly in both stretched and non-stretched samples during the 4-day incubation (Repeated measures ANOVA, (F2,6 = 32.7, P < 0.001) (Fig. 2A). Stretching the tissue for 10 min, 24 h after excision, partially suppressed the rise in TGF-β1. In the time course experiment, tissue exposed to stretch had significantly lower overall mean TGF-β1 levels compared with non-stretched tissue (F1,3 = 64.6, P = 0.004), though there was no evidence that the time effect was different between stretch and non-stretch conditions (F2,6 = 1.4, P = 0.31) (Fig. 2A). In a larger number of samples tested at day 3, mean TGF-β1 protein levels were significantly lower in stretched samples compared with non-stretched samples (F1,26= 11.5, P = 0.002, N = 36) (Fig. 2B).
Fig. 2
Fig. 2
Effect of tissue stretch on TGF-β1 protein ex vivo. A: Time course of TGF-β1 protein levels in the culture media for non-stretched (closed circle, N = 4) and stretched (open circle, N = 4) mouse subcutaneous tissue explants on days 0, (more ...)
In contrast to TGF-β1, mean LDH levels decreased significantly over time from day 0 to day 3 (F2,4 = 6.9, P = 0.05) and were not significantly different in the stretched compared with the non-stretched samples (F1,2 = 0.10, P = 0.81) (Fig. 3A). This suggested that the overall amount of tissue injury was comparable between the stretched and non-stretched groups. This was further supported by cell viability staining of one pair of samples incubated with and without stretch, which showed a similar proportion of live and dead cells in both samples at day 3 (Fig. 3B,C): mean ± SE percent live cells per low power field (20×) were 54.2 ± 3.6% and 65.3 ± 3.6% in non-stretched and stretched samples, respectively (based on 500–600 cells counted for each sample).
Fig. 3
Fig. 3
Ex vivo tissue injury and cell viability assessment. A: Time course of LDH concentration in the culture media (marker of cell death) for non-stretched (closed circle, n = 4) and stretched (open circle, n = 4) mouse subcutaneous tissue explants on days (more ...)
In vivo microinjury model
Masson trichrome staining of tissue histological sections obtained 7 days post-injury showed increased collagen density within the injured subcutaneous tissue layer (Fig. 4B) compared with the contraleral non-injured side (Fig. 4A).
Fig. 4
Fig. 4
Mouse in vivo microinjury model. Effect of microinjury on mouse subcutaneous tissue newly formed collagen. A,B: Masson Trichrome (stains collagen blue) of paraffin-embedded histological sections cut perpendicular to the skin; arrowhead indicates subcutaneous (more ...)
Immunohistochemical staining of the subcutaneous tissue layer for Type-1 procollagen showed a uniform increase in Type-1 procollagen, a marker for newly formed collagen, throughout the fibroblast tissue population on injured side (Fig. 4D) compared with the non-injured side (Fig. 4C). Among the 21 mice randomized to stretch and no stretch (Fig. 5A), microinjury resulted in a significant increase in Type-1 procollagen in the absence of stretch (F1,19 = 16.2, P < 0.001). However, when injury was followed by tissue stretch, no significant difference between microinjury and no microinjury was found (F1,19 = 1.65, P = 0.21). Thus, tissue stretch attenuated the increase in Type-1 procollagen in response to injury (Fig. 5B,C).
Fig. 5
Fig. 5
Effect of tissue stretch in vivo on subcutaneous tissue Type-1 procollagen in mouse microinjury model. A: Mean ± SE procollagen percent staining area in non-injured versus injured sides, without stretch (N = 11) and with stretch (N = 10); B,C: (more ...)
In this study, two complementary approaches are employed to examine the effect of brief tissue stretch on TGF-β1 and connective tissue matrix remodeling. First, stretching mouse subcutaneous tissue explants by 20% for 10 min decreases soluble TGF-β1 levels measured 3 days after stretch. During the 4-day incubation, TGF-β1 levels in the culture media increase in both stretched and non-stretched samples; because some tissue trauma occurs at the time of excision, this progressive rise in TGF-β1 is consistent with an injury response. However, the increase in the level of TGF-β1 is slower in the samples that are briefly stretched for 10 min, compared with samples that are not stretched. Since TGF-β1 auto-induction is an important mechanism driving the increase in collagen synthesis following tissue injury (Cutroneo, 2003), we hypothesized that brief stretching of tissue following injury in vivo would decrease soluble TGF-β1 levels, attenuate TGF-β1 auto-induction and decrease new collagen deposition. Testing this hypothesis in a mouse subcutaneous tissue injury model showed that elongating the tissues of the trunk by 20–30% for 10 min twice a day significantly reduces the amount of subcutaneous new collagen 7 days following subcutaneous tissue injury.
The data presented in this paper support the long-standing, but poorly understood, physical therapy practice of using brief, judiciously applied stretching of tissues to treat excessive scarring, connective tissue adhesions, and contractures (Hardy, 1989; Cummings and Tillman, 1992). To date, studies of cultured cells and tissues examining the effect of mechanical forces on TGF-β1 and matrix remodeling have nearly exclusively employed prolonged (hours to days) cyclical or static stretch of low amplitude (less than 15% strain) (Stauber et al., 1996; Zhuang et al., 1996; Hirakata et al., 1997; Gutierrez and Perr, 1999; Lee et al., 1999; Hinz et al., 2001; Kessler et al., 2001; Grinnell and Ho, 2002; van Wamel et al., 2002; Atance et al., 2004; Sakata et al., 2004; Loesberg et al., 2005; Balachandran et al., 2006; Balestrini and Billiar, 2006;). Under normal physiological circumstances, some amount of static tissue tension or “prestress” is present to varying degrees in different parts of the body while prolonged, repetitive cyclical stretching of tissues occurs due breathing, arterial pulsations, and repetitive movements such as walking (Tomasek et al., 2002; Silver et al., 2003; Ingber, 2006). During wound healing or chronic pathological conditions such as fibrosis, tissue tension can slowly increase over days to weeks due to the contractile activity of myofibroblasts (Stopak and Harris, 1982; Tomasek et al., 1992; Arora et al., 1999; Grinnell, 2000; Hinz et al., 2001). It is generally accepted that, when applied over an extended time period in the presence of TGFβ, low amplitude static or cyclical stretch causes an increase in the synthesis and deposition of collagen (Leung et al., 1976; Lambert et al., 1992; Chiquet, 1999; Kessler et al., 2001; Grinnell and Ho, 2002; Atance et al., 2004; Balestrini and Billiar, 2006). Our results, in contrast, show that brief, moderate amplitude (20–30% strain) stretching of connective tissue decreases both TGF-β1 and collagen synthesis. This effect, opposite to that of prolonged stretch, highlights the critical importance of “dose” (i.e., duration, amplitude, frequency) in mechanically induced connective tissue remodeling.
Pharmacological approaches to inhibiting excessive collagen deposition and fibrosis have been evaluated in various studies aiming to decrease collagen production either directly using double stranded oligodeoxynucleotide decoys (Cutroneo and Ehrlich, 2006), or indirectly by inhibition of TGF-β1 using antisense oligonucleotides (Han et al., 2000; Isaka et al., 2000), TGF-β1 latency-associated peptide (Bottinger et al., 1996), Smad7 (Kanamaru et al., 2001; Roberts, 2002) or thrombospondin-1 (Yevdokimova et al., 2001). However, drug or gene therapies bring a new set of challenges and potential side effects (Lahn et al., 2005). Fully understanding the dose-related effects of mechanical stretch on TGF-β1 and collagen would encourage the development of therapies based on measured amounts of stretch that may decrease fibrosis at low cost, without pharmacological side effects, or risking blocking TGF-β1 protein completely, as it is necessary for normal development and cellular function.
Several possible mechanisms may contribute to decreasing released soluble TGF-β1 following tissue stretch. Our TGF-β1 assay measures soluble (non-matrix bound) latent and active TGF-β1, but not soluble pro-TGF-β1 (since proteolytic cleavage of the bonds between the TGF-β and its latency-associated protein is necessary for acid activation) (Annes et al., 2003). In the tissue explant model, TGF-β1 levels in the culture media reflected its combined rates of (1) mRNA expression, protein synthesis and secretion, (2) extracellular sequestering via binding of large latent TGF-β binding protein to the matrix, (3) cleavage and activation of latent TGF-β complexes by tissue enzymes (metalloproteinases and plasmin), (4) binding of activated TGF-β by cell membrane receptors and (5) breakdown of free activated TGF-β (Shi and Massague, 2003; Stamenkovic, 2003; Annes et al., 2004; Rifkin, 2005). The observed effect of tissue stretch on TGF-β1 levels in this study therefore may involve one or more of these mechanisms. We recently reported that tissue stretch causes dynamic cytoskeletal reorganization in mouse subcutaneous tissue fibroblasts both ex vivo and in vivo (Langevin et al., 2005, 2006b). Because integrin-mediated TGF-β activity is cytoskeletal-dependent (Munger et al., 1999), an interesting possibility is that stretch-induced fibroblast cytoskeletal reorganization may stabilize the latent TGF-β binding protein, preventing release of soluble TGF-β from the cell's surface. Studies are currently underway to investigate this potential mechanism.
The results of this study suggest that stretch-induced decrease in TGF-β1-mediated new collagen formation may be an important natural mechanism limiting excessive scarring and fibrosis following injury (Fig. 6). Reducing scar and adhesion formation using stretch and mobilization is especially important for internal tissue injuries and inflammation involving fascia and organs, as opposed to open wounds. For open wounds (including surgical incisions) and severe internal tears (such as a ruptured ligament or tendon), wound closure and strength are critical and thus a certain amount of scarring is necessary and inevitable. In the case of minor sprains and repetitive motion injuries, however, scarring is mostly detrimental since it can contribute to maintaining the chronicity of tissue stiffness, abnormal movement patterns, and pain (Langevin and Sherman, 2007). We have proposed that therapies that briefly stretch tissues beyond the habitual range of motion (physical therapy, massage, yoga, acupuncture) locally inhibit new collagen formation for several days after stretch and thus prevent and/or ameliorate soft tissue adhesions (Langevin et al., 2001, 2002, 2005, 2006a, 2007). Brief stretching of lung tissue beyond tidal volume during periodic sighing also may decrease fibrosis following lung injury, although to our knowledge this has not been studied. The model shown in Figure 6 can be further tested in other experimental injury models examining changes in collagen and signaling molecules downstream of TGF-β1 such as SMADS, connective tissue derived growth factor (CTGF) and plasminogen activation inhibitor (PAI-1) as well as cell and matrix constituents influenced by TGF-β1 such as α-smooth muscle actin and fibronectins.
Fig. 6
Fig. 6
Proposed model for healing of connective tissue injury in the absence (A,C,E) and presence (B,D,F) of tissue stretch. In this model, brief stretching of tissue beyond the habitual range of motion reduces soluble TGF-β1 levels (D) causing a decrease (more ...)
In summary, our results show that brief, 20-30% tissue stretch can attenuate the increase in both soluble TGF-β1 (ex vivo) and Type-1 procollagen (in vivo) following tissue injury. This decreased fibrogenic response with brief, moderate amplitude stretch is in marked contrast to the well-established increase in TGF-β1 and collagen following prolonged low amplitude mechanical stimulation. The amount, timing and duration of therapeutically applied stretch therefore is likely critical to obtain beneficial anti-fibrotic effects.
Acknowledgments
The authors thank Dr. Marilyn J. Cipolla, Dr. Robert J. Kelm Jr., Dr. Arthur R. Strauch, and Dr. Jason H. Bates for helpful discussion and Kirsten N. Storch for technical assistance. This work was funded by the NIH Center for Complementary and Alternative Medicine Research Grant RO1-AT01121 and supported by NIH Grant P20 RR16435 from the COBRE Program of the National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official vviews of NCCAM.
Footnotes
Dr. Cutroneo is Deceased.
  • Annes JP, Chen Y, Munger JS, Rifkin DB. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol. 2004;165:723–734. [PMC free article] [PubMed]
  • Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. 2003;116:217–224. [PubMed]
  • Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol. 1999;154:871–882. [PubMed]
  • Atance J, Yost MJ, Carver W. Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. J Cell Physiol. 2004;200:377–386. [PubMed]
  • Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan AP. An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch. Ann Biomed Eng. 2006;34:1655–1665. [PMC free article] [PubMed]
  • Balestrini JL, Billiar KL. Equibiaxial cyclic stretch stimulates fibroblasts to rapidly remodel fibrin. J Biomech. 2006;39:2983–2990. [PubMed]
  • Balza E, Borsi L, Allemanni G, Zardi L. Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett. 1988;228:42–44. [PubMed]
  • Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor beta. Biochim Biophys Acta. 1990;1032:79–87. [PubMed]
  • Bassols A, Massague J. Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem. 1988;263:3039–3045. [PubMed]
  • Bottinger EP, Factor VM, Tsang ML, Weatherbee JA, Kopp JB, Qian SW, Wakefield LM, Roberts AB, Thorgeirsson SS, Sporn MB. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci USA. 1996;93:5877–5882. [PubMed]
  • Chiquet M. Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol. 1999;18:417–426. [PubMed]
  • Cummings GS, Tillman LJ. Remodeling of dense connective tissue in normal adult tissues. In: Currier DP, Nelson RM, editors. Dynamics of human biologic tissues, Contemporary perspectives in rehabilitation. Philadelphia: F.A. Davis; 1992.
  • Cutroneo KR. How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis. J Cell Biochem. 2003;90:1–5. [PubMed]
  • Cutroneo KR, Ehrlich HP. Silencing or knocking out eukaryotic gene expression by oligodeoxynucleotide decoys. Crit Rev Eukaryot Gene Expr. 2006;16:1–8. [PubMed]
  • Grinnell F. Fibroblast-collagen-matrix contraction: Growth-factor signalling and mechanical loading. Trends Cell Biol. 2000;10:362–365. [PubMed]
  • Grinnell F, Ho CH. Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices. Exp Cell Res. 2002;273:248–255. [PubMed]
  • Gutierrez JA, Perr HA. Mechanical stretch modulates TGF-β1 and alpha 1(I) collagen expression in fetal human intestinal smooth muscle cells. Am J Physiol. 1999;277:G1074–G1080. [PubMed]
  • Han DC, Hoffman BB, Hong SW, Guo J, Ziyadeh FN. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol. 2000;278:F628–F634. [PubMed]
  • Hardy MA. The biology of scar formation. Phys Ther. 1989;69:1014–1024. [PubMed]
  • Hinz B, Mastrangelo D, Iselin CE, Chaponnier C, Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol. 2001;159:1009–1020. [PubMed]
  • Hirakata M, Kaname S, Chung UG, Joki N, Hori Y, Noda M, Takuwa Y, Okazaki T, Fujita T, Katoh T, Kurokawa K. Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney Int. 1997;51:1028–1036. [PubMed]
  • Ingber DE. Cellular mechanotransduction: Putting all the pieces together again. FASEB J. 2006;20:811–827. [PubMed]
  • Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, Hori M. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int. 2000;58:1885–1892. [PubMed]
  • Kahari VM, Olsen DR, Rhudy RW, Carrillo P, Chen YQ, Uitto J. Transforming growth factor-beta up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. Lab Invest. 1992;66:580–588. [PubMed]
  • Kanamaru Y, Nakao A, Mamura M, Suzuki Y, Shirato I, Okumura K, Tomino Y, Ra C. Blockade of TGF-beta signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol. 2001;166:2818–2823. [PubMed]
  • Kessler D, Dethlefsen S, Haase I, Plomann M, Hirche F, Krieg T, Eckes B. Fibroblasts in mechanically stressed collagen lattices assume a “synthetic” phenotype. J Biol Chem. 2001;276:36575–36585. [PubMed]
  • Lahn M, Kloeker S, Berry BS. TGF-beta inhibitors for the treatment of cancer. Expert Opin Investig Drugs. 2005;14:629–643. [PubMed]
  • Lambert CA, Soudant EP, Nusgens BV, Lapiere CM. Pretranslational regulation of extracellular matrix macromolecules and collagenase expression in fibroblasts by mechanical forces. Lab Invest. 1992;66:444–451. [PubMed]
  • Langevin HM, Sherman KJ. Pathophysiological model for chronic low back pain integrating connective tissue and nervous system mechanisms. Med Hypotheses. 2007;68:74–80. [PubMed]
  • Langevin HM, Churchill DL, Cipolla MJ. Mechanical signaling through connective tissue: A mechanism for the therapeutic effect of acupuncture. FASEB J. 2001;15:2275–2282. [PubMed]
  • Langevin HM, Churchill DL, Wu J, Badger GJ, Yandow JA, Fox JR, Krag MH. Evidence of connective tissue involvement in acupuncture. FASEB J. 2002;16:872–874. [PubMed]
  • Langevin HM, Bouffard NA, Badger GJ, Iatridis JC, Howe AK. Dynamic fibroblast cytoskeletal response to subcutaneous tissue stretch ex vivo and in vivo. Am J Physiol Cell Physiol. 2005;288:C747–C756. [PubMed]
  • Langevin HM, Bouffard NA, Badger GJ, Churchill DL, Howe AK. Subcutaneous tissue fibroblast cytoskeletal remodeling induced by acupuncture: Evidence for a mechanotransduction-based mechanism. J Cell Physiol. 2006a;207:767–774. [PubMed]
  • Langevin HM, Storch KN, Cipolla MJ, White SL, Buttolph TR, Taatjes DJ. Fibroblast spreading induced by connective tissue stretch involves intracellular redistribution of alpha- and beta-actin. Histochem Cell Biol. 2006b;125:487–495. [PubMed]
  • Langevin HM, Bouffard NA, Churchill DL, Badger GJ. Connective tissue fibroblast response to acupuncture: Dose-dependent effect of bi-directional needle rotation. J Alt Complement Med. 2007;13:355–360. [PMC free article] [PubMed]
  • Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18:816–827. [PubMed]
  • Lee A, Delhaas T, McCulloch A. Differential responses of adult cardiac fibroblasts to in vitro biaxial strain patterns. J Mol Cell Cardiol. 1999;31:1833–1843. [PubMed]
  • Leung DY, Glagov S, Mathews MB. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science. 1976;191:475–477. [PubMed]
  • Loesberg WA, Walboomers XF, van Loon JJ, Jansen JA. The effect of combined cyclic mechanical stretching and microgrooved surface topography on the behavior of fibroblasts. J Biomed Mater Res A. 2005;75:723–732. [PubMed]
  • Loo DT, Rillema JR. Measurement of cell death. Methods Cell Biol. 1998;57:251–264. [PubMed]
  • Morgan TE, Rozovsky I, Sarkar DK, Young-Chan CS, Nichols NR, Laping NJ, Finch CE. Transforming growth factor-beta1 induces transforming growth factor-beta1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia. Neuroscience. 2000;101:313–321. [PubMed]
  • Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D. The integrin alpha versus beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319–328. [PubMed]
  • Rifkin DB. Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability. J Biol Chem. 2005;280:7409–7412. [PubMed]
  • Roberts AB. The ever-increasing complexity of TGF-beta signaling. Cytokine Growth Factor Rev. 2002;13:3–5. [PubMed]
  • Sakata R, Ueno T, Nakamura T, Ueno H, Sata M. Mechanical stretch induces TGF-beta synthesis in hepatic stellate cells. Eur J Clin Invest. 2004;34:129–136. [PubMed]
  • Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700. [PubMed]
  • Shull S, Cutroneo KR. Glucocorticoids coordinately regulate procollagens type I and type III synthesis. J Biol Chem. 1983;258:3364–3369. [PubMed]
  • Silver FH, Siperko LM, Seehra GP. Mechanobiology of force transduction in dermal tissue. Skin Res Technol. 2003;9:3–23. [PubMed]
  • Sporn MB, Roberts AB. TGF-beta: Problems and prospects. Cell Regul. 1990;1:875–882. [PMC free article] [PubMed]
  • Stamenkovic I. Extracellular matrix remodelling: The role of matrix metalloproteinases. J Pathol. 2003;200:448–464. [PubMed]
  • Stauber WT, Knack KK, Miller GR, Grimmett JG. Fibrosis and intercellular collagen connections from four weeks of muscle strains. Muscle Nerve. 1996;19:423–430. [PubMed]
  • Stopak D, Harris AK. Connective tissue morphogenesis by fibroblast traction. I. Tissue culture observations. Dev Biol. 1982;90:383–398. [PubMed]
  • Tomasek JJ, Haaksma CJ, Eddy RJ, Vaughan MB. Fibroblast contraction occurs on release of tension in attached collagen lattices: Dependency on an organized actin cytoskeleton and serum. Anat Rec. 1992;232:359–368. [PubMed]
  • Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349–363. [PubMed]
  • Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem. 1988;263:7741–7746. [PubMed]
  • van Wamel AJ, Ruwhof C, van der Valk-Kokshoorn LJ, Schrier PI, van der Laarse A. Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes. Mol Cell Biochem. 2002;236:147–153. [PubMed]
  • Yevdokimova N, Wahab NA, Mason RM. Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol. 2001;12:703–712. [PubMed]
  • Zhuang H, Wang W, Tahernia AD, Levitz CL, Luchetti WT, Brighton CT. Mechanical strain-induced proliferation of osteoblastic cells parallels increased TGF-beta 1 mRNA. Biochem Biophys Res Commun. 1996;229:449–453. [PubMed]